Cargando…
Association of Body Weight With Response to Vitamin D Supplementation and Metabolism
IMPORTANCE: In the Vitamin D and Omega-3 Trial (VITAL), the effects of randomized vitamin D supplementation (cholecalciferol), 2000 IU/d, reduced the risk of several health outcomes among participants with normal, but not elevated, body weights. It was unclear whether weight had any association with...
Autores principales: | Tobias, Deirdre K., Luttmann-Gibson, Heike, Mora, Samia, Danik, Jacqueline, Bubes, Vadim, Copeland, Trisha, LeBoff, Meryl S., Cook, Nancy R., Lee, I-Min, Buring, Julie E., Manson, JoAnn E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856931/ https://www.ncbi.nlm.nih.gov/pubmed/36648947 http://dx.doi.org/10.1001/jamanetworkopen.2022.50681 |
Ejemplares similares
-
Effects of Vitamin D(3) Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL)
por: Chou, Sharon H, et al.
Publicado: (2021) -
VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population
por: LeBoff, Meryl S, et al.
Publicado: (2020) -
Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA‐3 TriaL (VITAL)
por: LeBoff, Meryl S, et al.
Publicado: (2020) -
Effect of Vitamin D(3) and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial
por: Orkaby, Ariela R., et al.
Publicado: (2022) -
A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles
por: Tikkanen, Jani T., et al.
Publicado: (2023)